Company: ICUI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000883984-25-000007
Chunk: 229

Company: ICU MEDICAL INC/DE
Filing Date: 2025-02-27
Form: 10-K
Item: Item 1
Chunk 229
---
 exercise term.  The table below summarizes the total time-based stock options granted, total valuation and the weighted-average assumptions (dollars and shares in thousands, except per option amounts): Year ended December 31, 2022Number of time-based options granted7,620 Grant-date fair value of options granted$540 Weighted-average assumptions for stock option valuation:Expected term (years)5.5Expected stock price volatility36.0 %Risk-free interest rate3.0 %Expected dividend yield— %Weighted-average grant-price per option$185.79 Weighted-average grant-date fair value per option$70.86 There were no stock options granted during the years ended December 31, 2024 and 2023.

90

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)

A summary of our stock option activity as of and for the year ended December 31, 2024 is as follows: SharesWeighted-Average Exercise Price Per ShareWeighted-Average Contractual Life (Years)Aggregate Intrinsic Value (in thousands)Outstanding at December 31, 2023459,828 $82.95 Granted— $— Exercised(351,688)$66.61 Forfeited or expired— $— Outstanding at December 31, 2024108,140 $136.12 2.21$3,963 Exercisable at December 31, 2024108,140 $136.12 2.21$3,963 Vested and expected to vest, December 31, 2024108,140 $136.12 2.21$3,963     The intrinsic values for options exercisable, outstanding and vested or expected to vest at December 31, 2024 are based on our closing stock price of $155.17 at December 31, 2024 and are before applicable taxes.    The following table presents information regarding stock option activity (in thousands): Year ended December 31,202420232022Intrinsic value of options exercised$18,651 $8,441 $17,340 Cash received from exercise of stock options$10,939 $4,022 $8,785 Tax benefit from stock option exercises$1,034 $1,733 $3